Novo Nordisk is predicting a 13% drop in sales in 2026. As the company’s patents on Ozempic expire, could cheaper, generic … source
Ozempic and similar weight loss drugs, known as GLP-1s, make people less hungry, but it doesn’t seem to stop them from going out to eat. Bloomberg...
Novo Nordisk A/S is slashing the cost of Ozempic for cash-paying patients to $499 a month through NovoCare and partnering with GoodRx Holdings Inc. to offer...
Novo Nordisk’s weight loss drugs Ozempic and Wegovy transformed the firm into a global pharmaceutical giant. But four years after Wegovy’s US launch, the Danish drugmaker’s...
Ozempic #Wegovy #obesity #diabetes #weightloss #healthcare #pharmaceuticals #novonordisk #drugs #leadership #CEO Novo … source
A CNBC investigation finds that Novo Nordisk’s Ozempic and Wegovy as well as other wildly popular obesity drugs are being actively counterfeited and illegally diverted from...
The former talk show host speaks out for the first time about her weight loss journey, sharing how she did it without using … source
Novo Nordisk A/S CEO Lars Fruergaard Jorgensen discusses the company’s acquisition of Catalent for for $16.5 billion and the … source
“Impact x Nightline” takes a look at how the rise in weight loss drugs like Ozempic, Mounjaro and Wegovy are impacting people’s … source
WW’s shares dropped more than 20% on Thursday after the media mogul’s announcement that she has decided not to stand for re-election at the annual shareholders’...
On this website we use first or third-party tools that store small files (cookie) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to suitable advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.